VINTHER JACK (US)
FMC AGRO SINGAPORE PTE LTD (SG)
WO2021188653A1 | 2021-09-23 | |||
WO2011006896A2 | 2011-01-20 | |||
WO2020117493A1 | 2020-06-11 | |||
WO2003015519A1 | 2003-02-27 |
US20060223816A1 | 2006-10-05 |
"The Pesticide Manual", 2003, BRITISH CROP PROTECTION COUNCIL
"The BioPesticide Manual", 2001, BRITISH CROP PROTECTION COUNCIL
R. HILFIKER: "Polymorphism in the Pharmaceutical Industry", 2006, WILEY-VCH
CLAIMS What is claimed is: 1. A composition comprising: (a) a crystalline organic pesticide, (b) a carboxylic acid compound of Formula 1, (c) an aniline compound , (d) an amine base and (e) an aprotic solvent. 2. A composition of Claim 1 wherein the crystalline organic pesticide is a crystalline compound of Formula 4, wherein R1 is CH3 or Cl; R2 is Br, Cl, I or CN; R3 is H or C1-C4 alkyl; R4 is Cl, Br, CF3, OCF2H or OCH2CF3; R5 is F, Cl or Br; R6 is H, F or Cl; Z is CR7 or N; and R7 is H, F, Cl or Br; 3. The composition of Claim 2 wherein the amine base is selected from optionally substituted pyridines. 4. The composition of Claim 3 wherein the amine base is 3-picoline. 5. The composition of Claim 2 wherein the aprotic solvent is acetonitrile. 6. The composition of Claim 2 wherein R1 is CH3; R2 is Cl or CN; R3 is CH3; R4 is Br; R5 is Cl; R6 is H; Z is N. 7. The composition of Claim 6 wherein the crystalline compound of Formula 4 is chlorantraniliprole. 8. The composition of Claim 6 wherein the crystalline compound of Formula 4 is cyantraniliprole. 9. The composition of Claims 1 to 8 wherein the amount of crystalline compound of Formula 4 is 5 mol% to 30 mol% per mol of the carboxylic acid compound of Formula 1. 10. The composition of Claim 9 wherein the amount of crystalline compound of Formula 4 is 10 mol% to 25 mol% per mol of the carboxylic acid compound of Formula 1. 11. The method to prepare a compound of Formula 4-A, wherein R1 is CH3 or Cl; R2 is Br, Cl, I or CN; R3 is H or C1-C4 alkyl; R4 is Cl, Br, CF3, OCF2H or OCH2CF3; R5 is F, Cl or Br; R6 is H, F or Cl; Z is CR7 or N; and R7 is H, F, Cl or Br the method comprising the steps of: (1) forming the composition of Claim 1; (2) reacting the composition of Claim 1 with a sulfonyl chloride compound of Formula 3, R8S(O)2C1 3 wherein R8 is carbon-based radical; and (3) allowing the coupling of the acid activated mixture to proceed for the formation of a compound of Formula 4-A. 12. The method of Claim 11 wherein the sulfonyl chloride compound of Formula 3 is methanesulfonyl chloride. 13. The method of Claim 11 further comprising the step of: (4) adding water to the reaction. 14. The method of Claim 13 wherein R1 is CH3; R2 is Cl or CN; R3 is CH3; R4 is Br; R5 is Cl; R6 is H; Z is N. 15. The method of Claim 14 wherein the compound of Formula 4-A is chlorantraniliprole. 16. The method of Claim 14 wherein the compound of Formula 4-A is cyantraniliprole. 17. An organic pesticide of Formula 4-A formed using the composition of Claim 2. 18. The organic pesticide of Claim 17 wherein, the compounds of Formulae 4 and 4-A are both chlorantraniliprole. 19. The organic pesticide of Claim 17 wherein, the compounds of Formulae 4 and 4-A are both cyantraniliprole. |
Embodiment C38. The composition of any one of Embodiments C1 to C35 wherein the crystalline organic pesticide is an herbicide. Embodiment C39. The composition of any one of Embodiments C1 to C35 wherein the crystalline organic pesticide is a nematocide.
Embodiment C40. The composition of any one of Embodiments C1 to C35 wherein the crystalline organic pesticide is an insecticide.
Embodiment C41. The composition of any one of Embodiments C1 to C35 wherein the crystalline organic pesticide is selected from chlorantraniliprole, cyantraniliprole, flutriafol, indoxacarb, imidacloprid, fluindapyr and combinations thereof.
Embodiment C42. The composition of any one of Embodiments C1 to C35 wherein the organic pesticide is an anthranilic diamide of Formula 4, Embodiment C43. The composition of any one of Embodiments C1 to C35 wherein the crystalline organic pesticide is selected from chlorantraniliprole and cyantraniliprole.
Embodiment C44. The composition of any one of Embodiments C1 to C35 wherein the crystalline organic pesticide is chlorantraniliprole. Embodiment C45. The composition of any one of Embodiments C1 to C35 wherein the crystalline organic pesticide is cyantraniliprole.
Embodiment M1. The method as described in the Summary’ to prepare a compound of Formula 4-A comprising the steps of: (1) forming the composition of any one of Embodiments C1 to C45; (2) reacting the composition with a sulfbnyl chloride compound of Formula 3; and (3) allowing the activated mixture to proceed for the formation of a compound of Formula 4-A. Embodiment M2. The method of Embodiment M1 wherein the molar ratio of the sulfonyl chloride of Formula 3 to the compound of Formula 1 is at least about 1:1. Embodiment M3. The method of any one of Embodiments M1 to M2 wherein the molar ratio of the sulfonyl chloride of Formula 3 to the compound of Formula 1 is from about 1:1 to about 2.5:1. Embodiment M4. The method of any one of Embodiments M1 to M3 wherein the molar ratio of the sulfonyl chloride of Formula 3 to the compound of Formula 1 is from about 1.1:1 to about 1.4:1. Embodiment M5. The method of any one of Embodiments M1 to M4 wherein when R 2 is Br, Cl or I, then the molar ratio of the sulfonyl chloride of Formula 3 to the compound of Formula 1 is about 1.2:1. Embodiment M6. The method of any one of Embodiments M1 to M4 wherein when R 2 is CN, then the molar ratio of the sulfonyl chloride of Formula 3 to the compound of Formula 1 is about 1.3:1. Embodiment M7. The method of any one of Embodiments M1 to 6 wherein R 8 is C 1 - C 4 alkyl, C 1 -C 2 haloalkyl, or phenyl optionally substituted with 1–3 substituents selected from the group consisting of halogen, C 1 -C 3 alkyl and nitro. Embodiment M8. The method of any one of Embodiments M1 to M7 wherein R 8 is C 1 - C 2 alkyl, CF 3 , phenyl or 4-methylphenyl. Embodiment M9. The method of any one of Embodiments M1 to M8 wherein R 8 is C 1 - C 2 alkyl, phenyl or 4-methylphenyl. Embodiment M10. The method of any one of Embodiments M1 to M9 wherein R 8 is CH 3 . Embodiment M11. The method of any one of Embodiments M1 to M10 wherein the temperature of the composition is between about –70 and 100 °C before reacting with the sulfonyl chloride of Formula 3. Embodiment M12. The method of any one of Embodiments M1 to M11 wherein the temperature of the composition is between about –10 and 50 °C. Embodiment M13. The method of any one of Embodiments M1 to M11 wherein the temperature of the composition is between about 10 and 40 °C. Embodiment M14. The method of Embodiments any one of M1 to M11 wherein the temperature is about 20 °C. Embodiment M15. The method of any one of Embodiments M1 to M14 further comprising the step of: (4) adding water to the reaction. Embodiment M16. The method of Embodiment M15 wherein the molar ratio of water to the compound of Formula 1 is at least 1:1. Embodiment M17. The method of Embodiment M15 wherein the molar ratio of water to the compound of Formula 1 is from about 1:1 to about 100:1. Embodiment M18. The method of Embodiment M15 wherein the molar ratio of water to the compound of Formula 1 is from about 10:1 to about 50:1. Embodiment M19. The method of Embodiment M15 wherein the molar ratio of water to the compound of Formula 1 is from about 15:1 to about 40:1. Embodiment M20. The method of Embodiment M15 wherein the molar ratio of water to the compound of Formula 1 is from about 20:1 to about 35:1. Embodiment M21. The method of any one of Embodiments M15 to M20 wherein the temperature during addition of water is between about –70 and 100 °C. Embodiment M22. The method of any one of Embodiments M15 to M20 wherein the temperature during addition of water position is between about 0 and 80 °C. Embodiment M23. The method of any one of Embodiments M15 to M20 wherein the temperature during addition of water is between about 15 and 75 °C. Embodiment M24. The method of any one of Embodiments M15 to M20 wherein the temperature during addition of water is between about 20 and 65 °C. Embodiment M25. The method of any one of Embodiments M15 to M20 wherein the temperature during addition of water is between about 40 and 60 °C. Embodiment M26. The method of any one of Embodiments M15 to M20 wherein the temperature during addition of water is at least 50 °C. Embodiment M27. The method of any one of Embodiments M15 to M20 wherein the temperature during addition of water is about 65 °C. Embodiment F1. The compound of Formula 4-A is prepared by the method of any one of Embodiments M1 to M27. Embodiment F2. The composition of Embodiment F1 wherein R 5 is C1. Embodiment F3. The composition of any one of Embodiments F1 to F2 wherein R 1 is CH 3 . Embodiment F4. The composition of any one of Embodiments F1 to F3 wherein Z is N. Embodiment F5. The composition of any one of Embodiments F1 to F4 wherein R 4 is Cl, Br or CF 3 . Embodiment F6. The composition of any one of Embodiments F1 to F5 wherein R 2 is Cl or CN. Embodiment F7. The composition of any one of Embodiments F1 to F6 wherein R 4 is CH 3 , R 5 is Cl, R 6 is CH 3 , R 1 is Br, R 2 is Cl, R 3 is H, and Z is N. Embodiment F8. The composition of any one of Embodiments F1 to F6 wherein R 4 is CH 3 , R 5 is CN, R 6 is CH 3 , R 1 is Br, R 2 is Cl, R 3 is H, and Z is N. Embodiments C1 through C45; M1 through M27; F1 through F8; and any other Embodiment or Embodiments described herein can be combined in any manner, and the descriptions of variables in the embodiments pertain not only to anthranilic diamides of Formulae 4 and 4-A but also to the starting intermediate compounds of Formulae 1, 2 and 3 useful for preparing the organic pesticides. Of particular note is that methods of this disclosure prevent formation of highly viscous suspensions prior to reacting with sulfonyl chlorides of Formula 3. One skilled in the art will recognize viscous suspensions impede stirring resulting in reduced control of heat transfer and reagent mixing. One skilled in the art would further recognize reactor capacity and production scale is limited as further solvent addition is necessary to maintain reaction control resulting in increased production costs and waste. A feature of the present method provides an easily stirrable free flowing reaction suspension throughout the process and allows for convenient control of the coupling process as compared to previously known processes for the production of an organic pesticide such as an anthranilic diamide Formula 4-A. In some embodiments the present method provides increased production capacity of an organic pesticide resulting from the benefits of improved stirring, heat transfer and reaction control. In some embodiments, the crystalline organic pesticide may act as a nucleation source during crystallization of the organic pesticide. In some embodiments, the crystalline organic pesticide may lead to improved solid state characteristics in terms of larger crystals with more uniform crystal size distribution providing significantly reduced filtration times in operating the method on commercial scale and the need for time-consuming cleaning of the reactor from batch to batch. In various embodiments, wherein up to about 10 mol% of the crystalline organic pesticide is part of the composition in step (1), additional crystalline organic pesticide may be added after the addition of a part of the acid activating agent, such as at least about 5 mol% of the acid activating agent, or about 10 mol% to about 20 mol% of the activating agent, or about 15 mol% to about 20 mol% of the activating agent, in step (2). Alternatively, a reactor that has already produced the crystalline organic pesticide may be used in place of the crystalline organic pesticide, in step (1). In various embodiments, the methods of the disclosure may be conducted over a wide range of temperatures, but commonly it is conducted at temperatures ranging from –70 °C to 100 °C or from 0 °C to reflux or from 10 °C to 70 °C. In some embodiments, the reaction is conducted at a temperature of about 20 °C. One skilled in the art would recognize the temperature of the disclosed exothermic reaction is readily controlled by simply controlling the rate of addition of the sulfonyl chloride compound. The crystalline organic pesticides used in the composition of this disclosure are biologically active compounds or agents including crystalline forms of insecticides, fungicides, nematocides, bactericides, acaricides, herbicides, herbicide safeners, growth regulators such as insect molting inhibitors and rooting stimulants, chemosterilants, semiochemicals, repellents, attractants, pheromones, feeding stimulants and other biologically active compounds or entomopathogenic bacteria, virus or fungi. Examples of organic pesticides of this disclosure which may be used in the disclosed composition are insecticides such as abamectin, acephate, acequinocyl, acetamiprid, acrinathrin, acynonapyr, afidopyropen ([(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-3- [(cyclopropylcarbonyl)oxy]-1,3,4,4a,5,6,6a,12,12a,12b-decahy dro-6,12-dihydroxy-4,6a,12b- trimethyl-11-oxo-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano [3,4-e]pyran-4-yl]methyl cyclopropanecarboxylate), amidoflumet, amitraz, avermectin, azadirachtin, azinphos-methyl, benfuracarb, bensultap, benzpyrimoxan, bifenthrin, kappa-bifenthrin, bifenazate, bistrifluron, borate, broflanilide, buprofezin, cadusafos, carbaryl, carbofuran, cartap, carzol, chlorantraniliprole, chlorfenapyr, chlorfluazuron, chloroprallethrin, chlorpyrifos, chlorpyrifos-e, chlorpyrifos-methyl, chromafenozide, clofentezin, chloroprallethrin, clothianidin, cyantraniliprole, (3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6- [(methylamino)carbonyl]phenyl]-1H-pyrazole-5-carboxamide), cyclaniliprole (3-bromo-N- [2-bromo-4-chloro-6-[[(1-cyclopropylethyl)amino]carbonyl]phe nyl]-1-(3-chloro-2- pyridinyl)-1H-pyrazole-5-carboxamide), cycloprothrin, cycloxaprid ((5S,8R)-1-[(6-chloro-3- pyridinyl)methyl]-2,3,5,6,7,8-hexahydro-9-nitro-5,8-Epoxy-1H -imidazo[1,2-a]azepine), cyenopyrafen, cyflumetofen, cyfluthrin, beta-cyfluthrin, cyhalodiamide, cyhalothrin, gamma- cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, dicloromesotiaz, dieldrin, diflubenzuron, dimefluthrin, dimehypo, dimethoate, dimpropyridaz, dinotefuran, diofenolan, emamectin, emamectin benzoate, endosulfan, esfenvalerate, ethiprole, etofenprox, epsilon-metofluthrin, etoxazole, fenbutatin oxide, fenitrothion, fenothiocarb, fenoxycarb, fenpropathrin, fenvalerate, fipronil, flometoquin (2-ethyl-3,7-dimethyl-6-[4-(trifluoromethoxy)phenoxy]-4- quinolinyl methyl carbonate), flonicamid, fluazaindolizine, flubendiamide, flucythrinate, flufenerim, flufenoxuron, flufenoxystrobin (methyl (^E)-2-[[2-chloro-4- (trifluoromethyl)phenoxy]methyl]-^-(methoxymethylene)benzene acetate), fluensulfone (5- chloro-2-[(3,4,4-trifluoro-3-buten-1-yl)sulfonyl]thiazole), fluhexafon, fluopyram, flupiprole (1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-5-[(2-methyl-2-p ropen-1-yl)amino]-4- [(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile), flupyradifurone (4-[[(6-chloro-3- pyridinyl)methyl](2,2-difluoroethyl)amino]-2(5H)-furanone), flupyrimin, fluvalinate, tau-fluvalinate, fluxametamide, fonophos, formetanate, fosthiazate, gamma-cyhalothrin, halofenozide, heptafluthrin ([2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl 2,2- dimethyl-3-[(1Z)-3,3,3-trifluoro-1-propen-1-yl]cyclopropanec arboxylate), hexaflumuron, hexythiazox, hydramethylnon, imidacloprid, indoxacarb, insecticidal soaps, isofenphos, isocycloseram, kappa-tefluthrin, lambda-cyhalothrin, lufenuron, malathion, meperfluthrin ([2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl (1R,3S)-3-(2,2-dichloroethenyl)-2,2- dimethylcyclopropanecarboxylate), metaflumizone, metaldehyde, methamidophos, methidathion, methiocarb, methomyl, methoprene, methoxychlor, metofluthrin, methoxyfenozide, epsilon-metofluthrin, epsilon-momfluorothrin, monocrotophos, monofluorothrin ([2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl 3-(2-cyano-1- propen-1-yl)-2,2-dimethylcyclopropanecarboxylate), nicotine, nitenpyram, nithiazine, novaluron, noviflumuron, oxamyl, oxazosulfyl, parathion, parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, profluthrin, propargite, protrifenbute, pyflubumide (1,3,5-trimethyl-N-(2-methyl-1-oxopropyl)-N-[3-(2- methylpropyl)-4-[2,2,2-trifluoro-1-methoxy-1-(trifluoromethy l)ethyl]phenyl]-1H-pyrazole- 4-carboxamide), pymetrozine, pyrafluprole, pyrethrin, pyridaben, pyridalyl, pyrifluquinazon, pyriminostrobin (methyl (^E)-2-[[[2-[(2,4-dichlorophenyl)amino]-6-(trifluoromethyl)- 4- pyrimidinyl]oxy]methyl]-^-(methoxymethylene)benzeneacetate), pyriprole, pyriproxyfen, rotenone, ryanodine, silafluofen, spinetoram, spinosad, spirodiclofen, spiromesifen, spiropidion, spirotetramat, sulprofos, sulfoxaflor (N-[methyloxido[1-[6-(trifluoromethyl)-3- pyridinyl]ethyl]-^ 4 -sulfanylidene]cyanamide), tebufenozide, tebufenpyrad, teflubenzuron, tefluthrin, kappa-tefluthrin, terbufos, tetrachlorantraniliprole, tetrachlorvinphos, tetramethrin, tetramethylfluthrin ([2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl 2,2,3,3- tetramethylcyclopropanecarboxylate), tetraniliprole, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tioxazafen (3-phenyl-5-(2-thienyl)-1,2,4-oxadiazole), tolfenpyrad, tralomethrin, triazamate, trichlorfon, triflumezopyrim (2,4-dioxo-1-(5-pyrimidinylmethyl)-3- [3-(trifluoromethyl)phenyl]-2H-pyrido[1,2-a]pyrimidinium inner salt), triflumuron, tyclopyrazoflor, zeta-cypermethrin, Bacillus thuringiensis delta-endotoxins, entomopathogenic bacteria, entomopathogenic viruses or entomopathogenic fungi. Further examples of organic pesticides of this disclosure which may be used in the disclosed composition are: fungicides such as acibenzolar-S-methyl, aldimorph, ametoctradin, aminopyrifen, amisulbrom, anilazine, azaconazole, azoxystrobin, benalaxyl (including benalaxyl-M), benodanil, benomyl, benthiavalicarb (including benthiavalicarb-isopropyl), benzovindiflupyr, bethoxazin, binapacryl, biphenyl, bitertanol, bixafen, blasticidin-S, boscalid, bromuconazole, bupirimate, buthiobate, carboxin, carpropamid, captafol, captan, carbendazim, chloroneb, chlorothalonil, chlozolinate, copper hydroxide, copper oxychloride, copper sulfate, coumoxystrobin, cyazofamid, cyflufenamid, cymoxanil, cyproconazole, cyprodinil, dichlobentiazox, dichlofluanid, diclocymet, diclomezine, dicloran, diethofencarb, difenoconazole, diflumetorim, dimethirimol, dimethomorph, dimoxystrobin, diniconazole (including diniconazole-M), dinocap, dipymetitrone, dithianon, dithiolanes, dodemorph, dodine, econazole, etaconazole, edifenphos, enoxastrobin (also known as enestroburin), epoxiconazole, ethaboxam, ethirimol, etridiazole, famoxadone, fenamidone, fenaminstrobin, fenarimol, fenbuconazole, fenfuram, fenhexamide, fenoxanil, fenpiclonil, fenpicoxamid, fenpropidin, fenpropimorph, fenpyrazamine, fentin acetate, fentin hydroxide, ferbam, ferimzone, flometoquin, florylpicoxamid, fluopimomide, fluazinam, fludioxonil, flufenoxystrobin, fluindapyr, flumorph, fluopicolide, fluopyram, fluoxapiprolin, fluoxastrobin, fluquinconazole, flusilazole, flusulfamide, flutianil, flutolanil, flutriafol, fluxapyroxad, folpet, fthalide (also known as phthalide), fuberidazole, furalaxyl, furametpyr, hexaconazole, hymexazole, guazatine, imazalil, imibenconazole, iminoctadine albesilate, iminoctadine triacetate, inpyrfluxam, iodicarb, ipconazole, ipfentrifluconazole, ipflufenoquin, isofetamid, iprobenfos, iprodione, iprovalicarb, isoflucypram, isoprothiolane, isopyrazam, isotianil, kasugamycin, kresoxim-methyl, lancotrione, mancozeb, mandipropamid, mandestrobin, maneb, mapanipyrin, mefentrifluconazole, mepronil, meptyldinocap, metalaxyl (including metalaxyl-M/mefenoxam), metconazole, methasulfocarb, metiram, metominostrobin, metyltetraprole, metrafenone, myclobutanil, naftitine, neo-asozin (ferric methanearsonate), nuarimol, octhilinone, ofurace, orysastrobin, oxadixyl, oxathiapiprolin, oxolinic acid, oxpoconazole, oxycarboxin, oxytetracycline, penconazole, pencycuron, penflufen, penthiopyrad, perfurazoate, phosphorous acid (including salts thereof, e.g., fosetyl- aluminm), picoxystrobin, piperalin, polyoxin, probenazole, prochloraz, procymidone, propamocarb, propiconazole, propineb, proquinazid, prothiocarb, prothioconazole, pydiflumetofen (Adepidyn®), pyraclostrobin, pyrametostrobin, pyrapropoyne, pyraoxystrobin, pyraziflumid, pyrazophos, pyribencarb, pyributacarb, pyridachlometyl, pyrifenox, pyriofenone, perisoxazole, pyrimethanil, pyrifenox, pyrrolnitrin, pyroquilon, quinconazole, quinmethionate, quinofumelin, quinoxyfen, quintozene, silthiofam, sedaxane, simeconazole, spiroxamine, streptomycin, sulfur, tebuconazole, tebufloquin, teclofthalam, tecloftalam, tecnazene, terbinafine, tetraconazole, thiabendazole, thifluzamide, thiophanate, thiophanate-methyl, thiram, tiadinil, tolclofos-methyl, tolprocarb, tolyfluanid, triadimefon, triadimenol, triarimol, triazoxide, tribasic copper sulfate, triclopyricarb, tridemorph, trifloxystrobin, triflumizole, trimoprhamide tricyclazole, trifloxystrobin, triforine, triticonazole, uniconazole, validamycin, valifenalate (also known as valifenal), vinclozolin, zineb, ziram, zoxamide and 1-[4-[4-[5-(2,6-difluorophenyl)-4,5-dihydro-3-isoxazolyl]-2- thiazolyl]-1-piperidinyl]-2-[5-methyl-3-(trifluoromethyl)-1H -pyrazol-1-yl]ethanone; nematocides such as fluopyram, spirotetramat, thiodicarb, fosthiazate, abamectin, iprodione, fluensulfone, dimethyl disulfide, tioxazafen, 1,3-dichloropropene (1,3-D), metam (sodium and potassium), dazomet, chloropicrin, fenamiphos, ethoprophos, cadusaphos, terbufos, imicyafos, oxamyl, carbofuran, tioxazafen, Bacillus firmus and Pasteuria nishizawae; bactericides such as streptomycin; acaricides such as amitraz, chinomethionat, chlorobenzilate, cyhexatin, dicofol, dienochlor, etoxazole, fenazaquin, fenbutatin oxide, fenpropathrin, fenpyroximate, hexythiazox, propargite, pyridaben and tebufenpyrad. General references for organic pesticides (i.e. insecticides, fungicides, nematocides, acaricides, herbicides and biological agents) include The Pesticide Manual, 13th Edition, C. D. S. Tomlin, Ed., British Crop Protection Council, Farnham, Surrey, U.K., 2003 and The BioPesticide Manual, 2 nd Edition, L. G. Copping, Ed., British Crop Protection Council, Farnham, Surrey, U.K., 2001. In some embodiments a material with a similar crystal structure or similar crystal structure characteristics as the compounds of Formula 4-A may be used as a heterogeneous nucleation source to form and grow desired product crystals. Materials with crystal structures similar to the compounds of Formula 4-A may also be used to induce beneficial polymorphic characteristics that result in improved chemical reaction processes. An organic pesticide of Formula 4-A is formed when the starting compounds of Formulae 1, 2 and 3 are contacted with each other in a combined liquid phase, in which each is at least partially soluble. Particularly as the starting materials of Formulae 1 and 2 are typically solids at ordinary ambient temperatures, the method is most satisfactorily conducted using a solvent in which the starting compounds have significant solubility. Thus typically the method is conducted in a liquid phase comprising a solvent. In some cases the carboxylic acid of Formula 1 may have only slight solubility but its salt with added base may have more solubility in the solvent. Suitable solvents for this method include nitriles such as acetonitrile and propionitrile; esters such as methyl acetate, ethyl acetate, and butyl acetate; ketones such as acetone, methyl ethyl ketone (MEK), and methyl butyl ketone; haloalkanes such as dichloromethane and trichloromethane; ethers such as ethyl ether, methyl tert-butyl ether, tetrahydrofuran (THF), and p-dioxane; aromatic hydrocarbons such as benzene, toluene, chlorobenzene, and dichlorobenzene; tertiary amines such as trialkylamines, dialkylanilines, and optionally substituted pyridines; and mixtures of the foregoing. Solvents of note include acetonitrile, proprionitrile, ethyl acetate, acetone, MEK, dichloromethane, methyl tert-butyl ether, THF, p-dioxane, toluene, and chlorobenzene. Of particular note as solvent is acetonitrile, as it often provides products in superior yield and/or purity. As the reaction of the present method generates hydrogen chloride as a byproduct, which would otherwise bind to basic centers on the compounds of Formulae 1, 2 and 4, the method is most satisfactorily conducted in the presence of at least one added base. The base can also facilitate constructive interaction of the carboxylic acid with the sulfonyl chloride compound and the anthranilamide. Reaction of an added base with the carboxylic acid of Formula 1 forms a salt, which may have greater solubility than the carboxylic acid in the reaction medium. Although the base may be added at the same time, in alternation, or even after the addition of the sulfonyl chloride, the base is typically added before the addition of the sulfonyl chloride. Some solvents such as tertiary amines also serve as bases, and when these are used as solvents they will be in large stoichiometric excess as bases. When the base is not used as solvent the nominal mole ratio of the base charged to the sulfonyl chloride charged is typically from about 2.0 to 2.2, and is preferably from about 2.1 to 2.2. Preferred bases are tertiary amines, including substituted pyridines. More preferred bases include 2-picoline, 3-picoline, 2,6-lutidine, and pyridine. Of particular note as base is 3-picoline, as its salts with carboxylic acids of Formula 1 are often highly soluble in solvents such as acetonitrile. Typically more than one solid form can exist in the production of anthranilic diamides of Formulae 4 and 4-A. Thus, an anthranilic diamide of Formulae 4 and 4-A include all crystalline and non-crystalline forms of anthranilic diamides within the genus represented by Formulae 4 and 4-A. Non-crystalline forms include embodiments which are solids such as waxes and gums as well as embodiments which are liquids such as solutions and melts. Crystalline forms include embodiments which represent essentially a single crystal type and embodiments which represent a mixture of polymorphs (i.e. different crystalline types). The term “polymorph” refers to a particular crystalline form of a chemical compound that can crystallize in different crystalline forms, these forms having different arrangements and/or conformations of the molecules in the crystal lattice. Although polymorphs can have the same chemical composition, they can also differ in composition due the presence or absence of co- crystallized water or other molecules, which can be weakly or strongly bound in the lattice. Polymorphs can differ in such chemical, physical and biological properties as crystal shape, density, hardness, color, chemical stability, melting point, hygroscopicity, suspensibility, dissolution rate and biological availability. One skilled in the art will appreciate that a polymorph of anthranilic diamides of Formulae 4 and 4-A can exhibit beneficial effects (e.g., suitability for improved stirring, heat transfer and filtration) relative to another polymorph or a mixture of polymorphs of the same anthranilic diamide of Formulae 4 and 4-A. Preparation and isolation of a particular polymorph of anthranilic diamides of Formulae 4 and 4-A can be achieved by methods known to those skilled in the art including, for example, crystallization using selected solvents and temperatures. For a comprehensive discussion of polymorphism see R. Hilfiker, Ed., Polymorphism in the Pharmaceutical Industry, Wiley-VCH, Weinheim, 2006. Without further elaboration, it is believed that one skilled in the art using the preceding description can utilize the present disclosure to its fullest extent. The following examples are, therefore, to be construed as merely illustrative, and not limiting of the disclosure in any way whatsoever. Steps in the following examples illustrate a procedure for each step in an overall synthetic transformation, and the starting material for each step may not have necessarily been prepared by a particular preparative run whose procedure is described in other examples or steps. Ambient or room temperature is defined as about 20–25 °C. Percentages are by weight except where otherwise indicated. All patents and publications cited herein are fully incorporated by reference in their entirety. EXAMPLE 1 Preparation of 3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(met hylamino)- carbonyl]phenyl]-1H-pyrazole-5-carboxamide (cyantraniliprole) To a mixture of crystalline 3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2-methyl- 6-[(methylamino)carbonyl]phenyl]-1H-pyrazole-5-carboxamide (10.3 g, 0.020 mol), 3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxylic acid (see PCT Patent Publication WO 03/015519 for preparation) (40.0 g, 0.132 mol) and 2-amino-5-cyano- N,3-dimethylbenzamide (see PCT Patent Publication WO 03/015519 for preparation) (27.5 g, 0.142 mol) was added acetonitrile (123.5 g, 3.01 mol) and stirred at 20 °C. 3-picoline (34.5 g, 0.367 mol) was added over 5 min. Methanesulfonyl chloride (19.6 g, 0.171 mol) was added linearly over 1.5 h. The mixture was stirred for 2 h. Water (76.2 g, 4.23 mol) was added linearly over 1.2 h. The pH was adjusted to 1.1 with concentrated hydrochloric acid (4.37 g, 0.043 mol) and the mixture was stirred for 1 h. The pH was then adjusted to 3.3 with sodium hydroxide (4.34 g, 0.027 mol) and the mixture was stirred for 15 min. The mixture was filtered, and the resultant material was washed with aqueous acetonitrile (84% w/w, 43.0 g), then with acetonitrile (83.2 g), and dried to afford the title compound. Isolated Yield: 95% (seed corrected, based on 3-bromo-l-(3-chloro-2-pyridinyl)-1H-pyrazole- 5-carboxylic acid) Crystal Size Distribution: D[4,3] values were in the range of 50-65 µm containing a small amounts of fines EXAMPLE 2 Preparation of 3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(met hyl- amino)carbonyl]phenyl]-1H-pyrazole-5-carboxamide (cyantraniliprole) Cyantraniliprole was prepared, as in Example 1, in Experiments 1-10 and A-F using the parameters in Tables A, B and C below. Experiments 1-10 were conducted on a scale of 100 g of 3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxylic acid. Experiments A-F were conducted on a scale of 40 g of 3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxylic acid. Experiments A-F were conducted using a 5 cm diameter Büchner Funnel fitted with a Grade GF/B binder free glass fiber filter for filtration and washing the resultant material. The observations in Tables A and B were made after the addition of 3-picoline and prior to the addition of methanesulfonyl chloride. In Experiments 1-4 the stirring rate to obtain sufficient mixing was measured after the reaction mass thickened. As can be observed in Tables A and B, the addition of the crystalline organic pesticide to the reagents resulted in improved reaction suspension characteristics. The improved characteristics lead to lower rates of stirring necessary for sufficient reaction mixing. The improved characteristics also lead to agitation with lower solvent usage (i.e. higher reaction concentration). As can be observed in Table C, as less solvent is used, increased amounts of crystalline organic pesticide is required to control crystallization. The degree of crystallization control is illustrated by the correlation between larger D10 values and improved solid state qualities (i.e. faster filtration and washing times). D10 values indicate the particle size, wherein 10% of the sample contains particles that size or smaller. D50 values indicate the particle size, wherein 50% of the sample contains particles that size or smaller. D90 values indicate the particle size, wherein 90% of the sample contains particles that size or smaller. The abbreviation “Exp.” stands for “Experiment”. The abbreviation “rpm.” stands for revolutions per minute. Table A Description Exp 1 Exp 2 Exp 3 Exp 4 Exp 5 Description Exp 6 Exp 7 Exp 8 Exp 9 Exp 10 Table C Description Exp A Exp B Exp C Exp D Exp E Exp F EXAMPLE 3 Preparation of 3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(met hylamino)- carbonyl]phenyl]-1H-pyrazole-5-carboxamide (cyantraniliprole) Crystalline 3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(met hylamino)- carbonyl]phenyl]-1H-pyrazole-5-carboxamide (22.8 g, 0.043 mol), 3-bromo-1-(3-chloro- 2-pyridinyl)-1H-pyrazole-5-carboxylic acid (see PCT Patent Publication WO 03/015519 for preparation) (65.0 g, 0.214 mol), 2-amino-5-cyano-N,3-dimethylbenzamide (see PCT Patent Publication WO 03/015519 for preparation) (42.7 g, 0.221 mol) and acetonitrile (85.0 g, 2.07 mol) were charged into a 400 mL temperature controlled jacketed reactor equipped with a thermometer, an anchor-type mechanical stirrer, syringe pump and a reflux condenser. The mixture was agitated at 250 rpm, and the temperature was adjusted to 20 °C. 3-picoline (56.1 g, 0.596 mol) was added over 5 min. Methanesulfonyl chloride (31.8 g, 0.278 mol) was charged into the syringe and added linearly to the reaction mixture over 4.0 h. After the addition of methanesulfonyl chloride was complete, the reaction mixture was heated linearly to 50 °C over 2 h. Water (128.3 g, 7.12 mol) was added over 146.5 min according to the following dosing profile. Time (min) Total Water Added (g) Time (min) Total Water Added (g) Aft action mixture was cooled linearly to 20 °C over 30 min. The mixture was filtered, and the resultant material was washed with aqueous acetonitrile (84% w/w, 140.0 g), then with acetonitrile (135.0 g), and dried to afford the title compound. Isolated Yield: 95% (seed corrected, based on 3-bromo-l-(3-chloro-2-pyridinyl)-1H-pyrazole- 5-carboxylic acid) Crystal Size Distribution: D[4,3] values were in the range of 50-65 µm containing a small amounts of fines